It’s that time of the year! www.nephjc.com/news/2025/9/... #NephJC

KDIGO is pleased to announce the publication of the 2025 IgA Nephropathy (#IgAN) and IgA Vasculitis (#IgAV) Guideline, along with its Executive Summary in @kidneyint.bsky.social. Download: kdigo.co/KDIGO-IgAN-I... Read in KI: kdigo.co/KDIGO-IgAN-I... Exec Summary: kdigo.co/IgAN-IgAV-Gu...

Should we be considering the variability of a person's BP? Growing evidence that more variability is linked to poor outcomes. Maybe something for the 2033 BP guidelines... Long‐Term Blood Pressure Variability and Physical Performance in Older Adults - onlinelibrary.wiley.com/doi/10.1111/...

With SSaSS it was helpful to replace NaCl with KCl but with so much of the US eating pre-made/processed food, it would have to be at the manufacturer level to have an impact #NephJC

AUTHOR IN THE HOUSE!! #nephjc

Shellie Fravel, pharmacist joining from Iowa City. Excited to be here! #NephJC

Change is in the Autumn air 🌬️🍂 Join use only on #Bluesky on 9/16/25 at 9pm EST. We're discussing the 2025 ACC/AHA Hypertension Guideline Update. 🫀🫘🧠 #NephSky #MedSky www.nephjc.com/news/accaha2025-klno3

Seems like Apple Watch series 9 and above will get these features with the OS update apple.news/AXARtaiOQS9q...

As cystatin C use becomes more common - note other drugs (not just steroids) which can have an effect @alexchangmd.bsky.social and colleagues www.ajkd.org/article/S027... in @ajkd.bsky.social acetaminophen, opioids, lithium, furosemide among others #NephSky

Check out the latest @kireports.bsky.social community blog from @husamjz.bsky.social Anticoagulantion in ESRD patients with atrial fibrillation: www.kireportscommunity.org/post/bleeding-clotting-and-kidney-disease-in-atrial-fibrillation-can-factor-xi-inhibitors-change-the-g

Shellie Fravel - pharmacist joining from Iowa City tonight. Excited for this chat! #NephJC

Excellent summary of the ACHIEVE trial from @drsaivani.bsky.social & @thekidneywhisperer.bsky.social #NephJC chat tomorrow www.nephjc.com/news/achieve

It’s time to stop rounding serum creatinine url: academic.oup.com/ajhp/article...

Shellie Fravel, pharmacist joining from Iowa City. No COI. Excited for my first #NephJC book club tonight!

New 2025 AHA/ACC Hypertension Guideline dropped! www.jacc.org/doi/10.1016/... #hypertension #medsky #nephsky

When to use spironolactone, eplerenone or finerenone in the spectrum of cardiorenal diseases doi.org/10.1093/ndt/...

In the introduction, @johngreensbluesky.bsky.social drops some TB facts Annually more than a million people die of TB Overall, more than a *billion* people have died of TB in last 2 centuries That’s also something like 1 in 7 people who have ever lived 🤯 #NephJCBookClub

Latest episode of @freelyfiltered.bsky.social is live! This one on the two RCTs of DDAVP to prevent renal biopsy bleeding. We had special guest Vandana Niyyar join us. @medpeedskidneys.bsky.social @captainchloride.bsky.social www.nephjc.com/freelyfilter...

1/10 Last #NephJC we discussed HiLo: Hi vs Lo phos targets in HD patients #TenPostNephJC Can restricted diets & loading patients full of phos binders be filed under “Things We Do For No Reason,” or do we finally have proof these measures save lives? pubmed.ncbi.nlm.nih.gov/40638247/

Hi! I am Shellie Fravel, a pharmacist joining from Iowa City. No COI. Excited for the chat tonight! #NephJC

HiLo, HiLo it's off to work we go! ⛏️ Join us 9 pm EST 8/5/25 to discuss. #NephJC #NephSky Controlling Phos in patients on HD is a lot of work, but is it worth it? HiLo looks at hospitalization & death in low/high Phos goals. Will we finally have a RCT with answers ⁉️ www.nephjc.com/news/hilo-tr...

Last #NephJC we discussed the significance and causes of eGFRdiff, the difference between eGFR creatinine and cystatin C (eGFRdiff= eGFRcys-eGFRcr) #TenPostNephJC #NephSky Read the article 👇 pubmed.ncbi.nlm.nih.gov/40373998/

Shellie Fravel, pharmacist. No COI, excited for the discussion! #NephJC

Check out the VA from @drsaivani.bsky.social and @nephromommy-akshu.bsky.social on eGFRdiff in the CRIC cohort. #Nephsky #NephJC www.nephjc.com/news/cricdiff

#Flozins in ADPKD. Interesting VA data suggesting that they may be safe and have a role in renal preservation journals.lww.com/cjasn/fullte...

8/10 #NephJC Quote of the fortnight @hswapnil.medsky.social‬ and @christosargyrop.bsky.social ‬ quickly agreed on new treatment goals for DKD #ZeroAlbuminuria

🎨Check out the beautiful #visualabstract by #NephJC intern @shelliefravel.bsky.social ⏰Chat happening on July 8, 9 pm EST www.nephjc.com/news/2025/7/...

Shellie Fravel, pharmacist. No COI. Looking forward to learning more about the nudge trial tonight! #NephJC

Creatinine ≠ Cystatin C. Both estimate GFR—but what drives their discordance? Our @ajkd.bsky.social editorial explores what we do and don’t know about the non-GFR factors behind it. 📖 Read: shorturl.at/hK5qu 🔍 McCoy et al (AJKD, 2025): shorturl.at/NIuAL #eGFR #CKD

Disappointed the generic can only be dispensed by the same three pharmacies as the brand. I don’t get why our patients can’t choose to get tolvaptan from the specialty pharmacy at our institution where the pharmacists would have access to do the REMs monitoring and check LFTs before dispensing.

Happy Pride Month! ☮️ 🌈 ❤️

Follow them all here: go.bsky.app/7qJxtg

The class of 2025, #NephJC interns www.nephjc.com/news/2025/6/...

Just pushed an update to Healthicons.org with great new icons from our volunteer illustrators. New icons include: - Dry eyes - Autoimmune disease - CPAP - Social determinants of health - Tumor - Cell tissue - FHIR2 - IV drip and lots more!

Triple drug combo now available in US - approved by FDA Telmisartan 10 Amlodipine 1.25 Indapamide 0.625 george-medicines.com/george-medic... #Hypertension #Widaplik Also in higher doses: 20/2.5/1.25 and 40/5/2.5

Hi! I am Shellie Fravel, a pharmacist at the University of Iowa. Excited to learn tonight! #NephJC

Repeated damage from extreme heat over time seems to be a leading factor causing kidneys to fail https://go.nature.com/45L9NlX

Cardiovascular Disease Risk Estimates in the US CKD Population Using the PREVENT Equation bit.ly/WaltherOI25 #CKD

Complex Etiologies of the Discordance Between Cystatin C– and Creatinine-Based Estimated GFR and Its Adverse Associations: Findings From the CRIC Study bit.ly/McCoyOI25

Fenofibrate-Induced Osmotic Nephropathy: A Novel Mechanism of Acute Kidney Injury bit.ly/LinCR25 #AKI

Real-world challenges in the use of tolvaptan for ADPKD lead to high discontinuation rates and dosage adjustments, underscoring the need for standardized and improved management strategies to enhance tolerability and adherence. https://bit.ly/KID0816 @shelliefravel.bsky.social #ASNKidney360

The burden of chronic kidney disease continues to grow, affecting more than 850 million people worldwide. A letter discusses a resolution proposed by Guatemala on promoting kidney health and strengthening the prevention and control of kidney disease: tinyurl.com/mr2u6v9e

Amiloride was noninferior to spironolactone in lowering home systolic blood pressure at 12 weeks. https://ja.ma/42XMGD9

Excellent review including all the available data and pharmacology of commonly used drugs and breastfeeding in @kireports.bsky.social www.kireports.org/article/S246... #NephSky 1/2

Prevalence of actionable pharmacogenetic genotypes in older adults ascpt.onlinelibrary.wiley.com/share/7VM9X8...

Performance of the PREVENT calculator in older adults www.ahajournals.org/eprint/5N9IC...

⬇️ carbon dialysis👣. Did you know that if healthcare were a country, it would be the 5th largest polluter in the 🗺️ ? Initiatives like @theisn.org #GreenK & @kdigo.org Controversies Conference on #GreenDialysis are helping us understand the problem & 🔎sustainable solutions. ♻️

In case you missed it on the #AJKDBlog, Commentary by Suzanne El-Sayegh, Hachem Araji, and Nadim Zaidan: Gout and CKD: Harmonizing Urate Control with Patient-Centric Care bit.ly/40ynBvX (FREE)

Sex and the Relationship Between Cardiometabolic Risk Factors and Estimated GFR Decline: A Population-Based Cohort Study bit.ly/495w1Pi #OpenAccess #VisualAbstract

The withdrawal of brand-name fluticasone propionate was associated with increased discontinuation of inhaled steroid therapy among children with asthma using this drug. #PAS2025 https://ja.ma/42WC8D8#PAS2025